Overall rank by patents
#651
Across all tracked assignees
USPTO PatentsView assignee record - 689 granted patents across 57 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION).
The verdict
Saturn holds 689 US patents across 57 technology areas, rank #651 of 50,000 tracked assignees.
Saturn Licensing Llc has been granted 689 US utility patents between 2016 and 2025, placing Saturn Licensing Llc at rank #651 across all assignees tracked by PlainPatent. This portfolio spans 57 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION). As a US Corporation, Saturn Licensing Llc is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Saturn sits between University Of Washington (691 patents, rank #647) and The Brigham And Women's Hospital, Inc. (685 patents, rank #655) - the closest US assignees by grant volume. The composite Innovation Score of 63.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 447 grants, compared with 242 in the 2015–2019 window, a +85% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Saturn Licensing Llc's 18.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 57 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Saturn Licensing Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
University of Washington
691 patents
Immatics Biotechnologies GmbH
690 patents
Rivian IP Holdings, LLC
690 patents
Carl Zeiss Meditec AG
689 patents
SATURN LICENSING LLC
689 patents
The Research Foundation for The State University of New York
688 patents
EVONIK DEGUSSA GMBH
686 patents
GM Cruise Holdings LLC
685 patents
The Brigham and Women's Hospital, Inc.
685 patents
What this shows Saturn holds 689 patents at rank #651, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #651 in granted patent volume.
Other assignees with the most granted patents in Saturn's primary technology class.
Saturn's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
63 Top 2% higher than 98% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 0.1% |
| 2017 | 57 | 8.3% |
| 2018 | 95 | 13.8% |
| 2019 | 89 | 12.9% |
| 2020 | 98 | 14.2% |
| 2021 | 101 | 14.7% |
| 2022 | 93 | 13.5% |
| 2023 | 67 | 9.7% |
| 2024 | 59 | 8.6% |
| 2025 | 29 | 4.2% |
Top 15 of 57 technology areas
Overall rank by patents
#651
Across all tracked assignees
63.4 out of 100
How to use this portfolio
Saturn's 689 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.